期刊文献+

文拉法辛缓释剂与阿米替林治疗老年抑郁症的随访研究 被引量:3

Follow-up Study on Venlafaxine and Amitriptyline in Treatment of Elderly depression
下载PDF
导出
摘要 目的比较文拉法辛缓释剂(博乐欣)与阿米替林对老年抑郁症的治疗效果。方法将80例老年抑郁症患者按住院顺序分为两组,分别给予博乐欣和阿米替林进行为期8周的治疗,治疗结束后进行1年的随访。用汉密尔顿抑郁量表(HAM D)、抗抑郁药副反应量表(SERS)于治疗前、治疗中和出院后1年对患者进行疗效评估。结果治疗结束后两组显效率分别为75%和68.4%、有效率分别为97.5%和94.7%,两组比较P>0.05;治疗2周后博乐欣组和阿米替林组的HAM D分分别为22.4±2.8和26.7±3.2,P<0.05;治疗结束时两组SERS分分别为1.7±0.3和4.5±1.9,P<0.01;出院1年后博乐欣组8例复发,阿米替林组15例复发,两者有显著差异(χ2=5.5,P<0.05)。结论博乐欣是一种安全、有效的抗抑郁剂,比较适用于老年抑郁症患者。 Objective To evaluate the effects of Venlafaxine(Bolexin) and Amitriptyline in treatment of elderly depression.Methods A total of 80 cases of elderly hospitalized patients with depression were divided into two groups in turn for 8 weeks of treatment with Venlafaxine and Amitriptyline.After treatment,1 year of follow-up was conducted.The effects were assessed with the Hamilton Depression Scale(HAMD) and Side Effects Antidepressant Scale(SERS) before treatment,when treatment,and in 1 year after discharge.Results At the end of treatment,the significantly effective rates of the two groups were 75% and 68.4% respectively,the effective rates were 97.5% and 94.7% respectively(P〉0.05);two weeks after treatment,HAMD points of Venlafaxine group and amitriptyline group were(22.4±2.8) and(26.7±3.2) respectively(P〈0.05);At the end of the treatment,the SERS points of the two groups were(1.7±0.3) and(4.5±1.9) respectively(P〈0.01);After one year of discharge,8 cases of venlafaxine group and 15 cases of Amitriptyline group relapsed,there was significant differences(χ2=5.5,P〈 0.05).Conclusion Bolexin is a safe and effective antidepressant,is applicable to elderly depression.
出处 《中国健康心理学杂志》 2011年第1期12-13,共2页 China Journal of Health Psychology
关键词 文拉法辛缓释剂 阿米替林 老年抑郁症 Venlafaxine Amitriptyline Elderly depression
  • 相关文献

参考文献12

  • 1Wellington K, Perry C M, Venlafaxin-ER:a review of. its use in themanagement major depression[J]. CNS Drugs, 2001,15 (8) : 643-669.
  • 2顾牛范,李华芳,舒良,张鸿燕,翁正,张心保,欧红霞,周自强.文拉法辛缓释剂治疗抑郁症的双盲、随机、平行对照、多中心临床研究[J].中国新药与临床杂志,2002,21(2):66-71. 被引量:69
  • 3Judge R. Onee-daily venlafaxine extened release (XR) vs fluoxvtim for the treatment of depression[J]. J Clin Psychiatry.2001.62(11) :888-893.
  • 4Thase M E, Simons A D, McGeary J, et al. Relapse after cognitive behaviortherapy of depression: potential implications for tongercourse of treatmeat[J]. Am J Psychiatry.1992.149:1046-1052.
  • 5中国精神科学会.中国精神障碍分类与诊断标准[M].3版.济南:山东科学技术出版社,2001:75-78.
  • 6Harvey A T,Pudolph P L.Preskorn SH. Evidence of the dual rnechanisms ofaction of venlafaxin[J]. Arch Gcn Psychiatry. 2000, 57 (5) :503-509.
  • 7Holiday S M,Benfield P. Venlafaxine : a review of its Parmacologyand therapect potential in depression [J ]. Drug. 1995.49 (7) : 280-294.
  • 8Rudolph R L,Entsuah R,Chitra R A. Mete analysis of the effects ofvenlafaxine on anxiety associated wilh depression[J ]. J CIm Psychopharmacol, 1998,18 (2): 136-144.
  • 9郭春荣,张晓红.文拉法辛治疗广泛性焦虑症[J].中国新药与临床杂志,2001,20(2):117-119. 被引量:31
  • 10潘桂花,施慎逊,陆峥,张展星,徐筠.抑郁症的年复发率及其相关因素分析[J].上海精神医学,1998,10(1):26-29. 被引量:19

二级参考文献6

共引文献158

同被引文献45

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部